Meril Life Sciences has secured CE marking for its MISSO robotic surgical system, a regulatory milestone bringing the platform into compliance with the stringent regulatory standards governing medical devices across European healthcare systems — where clinical validation and precision standards are non-negotiable thresholds for market entry.
Related: FDA clears Varian’s TrueBeam systems for low-dose radiation therapy
The certification marks an early but significant step in Meril’s broader push into the global surgical robotics landscape, positioning the company alongside a growing field of players advancing active robotic technologies in orthopaedic arthroplasty from concept into clinical practice.
For Meril, the move reflects a deliberate and considered expansion beyond its established markets, as robotic-assisted joint replacement surgery continues its measured transition from emerging technology to accepted standard of care in leading healthcare systems worldwide.
